Cengiz Tarhan, will present ‘the trials and tribulations of running a successful TTO’, the first keynote presentation of TTS Australia. As Managing Director of University College London Business (UCL Business), Cengiz plays a pivotal role in commercialising the intellectual property created by UCL’s leading researchers.
Read Spotlight on Cengiz Tarhan from University of College London.
Discover how drug majors and drug developers play an essential role in advancing R&D pipelines.
The partnership between MSD and Bionomics will be used a case study, which is worth up US$506 million.
Bionomics recently received a US$10 million payment from MSD following the selection of one of its drug candidates for a clinical trial, which is for the treatment of Alzheimer’s related-cognitive dysfunction.
Read Adelaide drug developer Bionomics gets significant milestone payment from drug major from The Advertiser.